TMEM120B accelerated the cycling of β1-integrin and the assembling of FAs by activating the TAZ-mTOR signaling axis via binding to MYH9 through its coil-coil domain, thus strengthening proliferation and invasion, maintaining the stemness of breast cancer cells, and promoting chemoresistance. Here, TMEM120B is linked to breast cancer.